Viking Therapeutics (VKTX)
(Delayed Data from NSDQ)
$67.00 USD
-2.06 (-2.98%)
Updated May 17, 2024 04:00 PM ET
After-Market: $67.29 +0.29 (0.43%) 7:58 PM ET
3-Hold of 5 3
C Value F Growth A Momentum D VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
07/24/2024
Time: -- |
6/2024 | $-0.25 | 0.33% |
Earnings Summary
For their last quarter, Viking Therapeutics (VKTX) reported earnings of -$0.26 per share, beating the Zacks Consensus Estimate of $-0.27 per share. This reflects a positive earnings surprise of 3.70%. Look out for VKTX's next earnings release expected on July 24, 2024. For the next earning release, we expect the company to report earnings of -$0.25 per share, reflecting a year-over-year decrease of 31.58%.
Earnings History
Price & Consensus
Zacks News for VKTX
Should You Hold Viking Therapeutics (VKTX) in Your Portfolio?
VKTX: What are Zacks experts saying now?
Zacks Private Portfolio Services